Jeffrey A Meckler is of Travere Therapeutics, Inc.. Currently has a direct ownership of 81,000 shares of TVTX, which is worth approximately $1.48 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 40,000 shares (Common Stock) at a price of $14.06 per share, resulting in proceeds of $562,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81K
0% 3M change
8.72% 12M change
Total Value Held $1.48 Million

Jeffrey A Meckler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2024
SELL
Open market or private sale
$562,400 $14.06 p/Share
40,000 Reduced 33.06%
81,000 Common Stock
Sep 30 2024
BUY
Exercise of conversion of derivative security
$419,200 $10.48 p/Share
40,000 Added 24.84%
121,000 Common Stock
May 08 2024
BUY
Grant, award, or other acquisition
-
6,500 Added 7.43%
81,000 Common Stock
May 17 2023
BUY
Grant, award, or other acquisition
-
4,500 Added 5.7%
74,500 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
3,000 Added 4.11%
70,000 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
3,000 Added 4.29%
67,000 Common Stock

Also insider at

INDP
Indaptus Therapeutics, Inc. Healthcare
JAM

Jeffrey A Meckler

New York, NY

Track Institutional and Insider Activities on TVTX

Follow Travere Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX